Addiction Disorders
- Naloxone Access Not Associated With Adolescent Substance Use
- Recent SARS-CoV-2 Infection May Associate With Alcohol Use Disorders
- Amphastar Gets FDA Approval for Intranasal Naloxone Product
- A 24/7 Alcohol Monitoring Program Reduces Risk for Death in Half
- Primary Care Intervention Increases Prevention of Alcohol Use Disorder
- Perceived E-Cigarette Addiction Associates With Addiction Markers
- Those Who Smoke Heavily Have High Incidence of Undiagnosed COPD
- Methamphetamine Mortality Increased 50-Fold From 1999 to 2021
- FDA Restricts Unlawful Import of Xylazine-Containing Products
- US to Allow Medicaid to Pay for Drug Treatment in Prisons
- Alcohol Consumption Tied to Less Disease Activity With Rheumatoid Arthritis
- Risk for Alcohol Use Disorder Increased After COVID-19 Infection
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
